In Vivo Intralesional Positronium Lifetime Imaging of Thyroid Cancer Using Clinically Routine I-124 PET/CT
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Purpose
Measuring the lifetime of orthopositronium (oPs), the spin triplet of an electron and positron, has emerged as a promising approach for assessing tumor microen-vironment characteristics, leveraging the susceptibility of oPs lifetime to local molecular factors such as the oxygenation level. This study investigates the feasibility of intralesional oPs lifetime measurements in patients with thyroid cancer using a commercial long axial field-of-view (LAFOV) PET/CT scanner.
Methods
Three patients with thyroid cancer underwent two PET/CT scans on a Biograph Vision Quadra (Siemens Healthineers, Knoxville TN, USA) at 2 and 26 hours post-administration [ 124 I]NaI, which included a 30 min scan in singles mode (a prototype feature for saving single crystal interactions without coincidence sorting) that allows to identify three-photon events. For regions with high 124 I uptake, we determined the lifetime of oPs together with Bayesian errors estimation for a voxel-based (with a voxel size of 7 × 7 × 7 mm 3 ), lesion based and organ based analysis.
Results
The oPs lifetime of the voxel with the highest count statistics and activity concentration of 108.1 kBq mL −1 is 1.77 ± 0.26 ns. The visualization of the oPs lifetimes inside the tumor lesion was feasible, though it remains affected by statistical error. On a per-lesion basis, the lifetime could be measured (exemplary lesion:1.90 ± 0.17 ns) with mean activity concentrations ranging from 9.5 to 34.1 kBq mL −1 and volumes 1.31 to 6.27 kBq mL −1 . The positronium lifetime measurement error shows a slight correlation ( r =0.48 with BF 10 =7.88) with activity concentration of the regarded region. Besides lesions, the positronium lifetime could also be determined in several organs (average oPs lifetime in exemplary organs: liver 1.68 ± 0.08 ns, left atrium 1.83 ± 0.17 ns, right parotid gland: 2.24 ± 0.12 ns, left kidney 1.87 ± 0.12 ns).
Conclusion
This is the first report human in-vivo measurement of oPs lifetime with [ 124 I]NaI using a commercial LAFOV PET/CT scanner. The voxel-wise oPs lifetime imaging is feasible, though with a high statistical uncertainty. Lesion-based measurements can yield satisfactory statistical precision even for small volumes under clinical conditions. Future studies can leverage our approach to analyze the tumor microenvironment with regard to oPs lifetime as a surrogate marker for oxygenation.
